Scientist
Ono Pharmaceutical, Osaka, Japan
Kazuki Matsui, PhD. is a seasoned and passionate research scientist with over 15 years of industrial experiences, specializing in pharmacokinetics and biopharmaceutics.
His contributions to pharmaceutical sciences are exemplified by the development and validation of the Gastrointestinal Simulator (GIS), an in vivo predictive dissolution apparatus, under the guidance of Professors Gordon L. Amidon and Gregory E. Amidon at the College of Pharmacy, University of Michigan. He has also played a significant role in the international harmonization of regulatory guidelines, as a industry representative in two ICH expert working groups: ICH M9 (BCS-based biowaiver) and M13 (bioequivalence of immediate release dosage forms). He currently leads the Oral Absorption Focus Group within the Academy of Pharmaceutical Science and Technology, Japan (APST).
His research interests encompass a wide range of topics, including drug-drug interactions (DDI), pharmacokinetics/pharmacodynamics (PKPD), metabolite identification, biorelevant dissolution, bioequivalence, in vitro-in vivo correlation (IVIVC), formulation design, and physiologically based pharmacokinetic (PBPK) modeling for the oral absorption of new chemical entities. Kazuki is a (co-)author of over 20 articles published in esteemed scientific journals such as The AAPS Journal, Molecular Pharmaceutics, and the Journal of Pharmaceutical Sciences.
Disclosure information not submitted.
The Effect of Formulation Excipients for Oral Absorption in Pediatrics
Tuesday, November 11, 2025
10:30 AM - 11:00 AM CT